DRAP, Iranian FDA to collaborate for availability of life saving drugs.

 
FREE EXCERPT

ISLAMABAD -- The Drug Regulatory Authority of Pakistan (DRAP) and Iranian Food and Drug Administration (FDA) would collaborate for availability of life saving drugs and chalk out mutual cooperation mechanism.

Spokesman of DRAP said that an Iranian delegation of the government officials visited DRAP HQ here at Islamabad, said a press release issued by Press Information Department here Saturday.

The purpose of the visit was to scan the opportunities of mutual cooperation in the field of pharmaceutical manufacturing, availability of life-saving drugs and vaccines, growth of medical devices industry and surgical items.

Asim Rauf, Chief Executive Officer of DRAP briefed the Iranian delegation about the potential and needs of Pakistan's therapeutic goods industry.

The Iranian side showed confidence in starting a negotiation on the possible avenues of cooperation and to draw a roadmap for...

To continue reading

REQUEST YOUR TRIAL